In the past few years, scientists have been researching many types of complex human
diseases and traits through genomewide association studies (GWAS), such as diabetes …

In past five years, genome-wide association study (GWAS) has proven to be a powerful and
efficient study design in identifying genetic variants associated with complex diseases and …

Genomewide association study (GWAS) is a novel strategy for discovering genetic basis of
human complex disease or trait. It utilizes millions of single nucleotide polymorphisms …

Over the past decade, the number of genome-wide association studies (GWAS) carried out
has increased exponentially. These studies, mostly by investigating single nucleotide …

Novel, comprehensive approaches for biomarker discovery and validation are urgently
needed. One particular area of methodologic need is for discovery of novel genetic …

Genome-wide association studies (GWAS) have successfully identified numerous genetic
risk factors for many common phenotypes, such as diabetes, Crohn's disease or height …

Genome-wide association study (GWAS) is an observational study of a genome-wide set of
genetic variants in different individuals to see if any variant is associated with a trait. GWA …

Genome-wide association (GWA) studies are the method of choice for discovering loci
associated with common diseases. More than a thousand GWA studies have reported …

Genome-wide association studies (GWAS) involve testing genetic variants across the
genomes of many individuals to identify genotype–phenotype associations. GWAS have …

Genome-wide association study (GWAS) is a popular strategy in studying complex diseases.
GWAS genotypes 10 5∼ 10 6 single-nucleotide polymorphisms (SNPs) from thousands of …